UNITEDHEALTH GROUP INC (UNH) Stock Analyst Earnings Estimates
NYSE:UNH - New York Stock Exchange, Inc. - US91324P1021 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 287.597B 11.84% | 324.162B 12.71% | 371.622B 14.64% | 405.003B 8.98% | 454.533B 12.23% | 491B 8.02% | 531.011B 8.15% | 587.039B 10.55% | 603.981B 2.89% | 640.959B 6.12% | 678.6B 5.87% | 718.618B 5.90% | |
| EBITDA YoY % growth | 27.073B 7.02% | 31.835B 17.59% | 36.33B 14.12% | 39.165B 7.80% | 42.996B 9.78% | 47.351B 10.13% | 52.253B 10.35% | 57.041B 9.16% | 62.466B 9.51% | 65.877B 5.46% | 69.49B 5.48% | 73.32B 5.51% | |
| EBIT YoY % growth | 23.97B 6.99% | 28.435B 18.63% | 32.358B 13.80% | 36.421B 12.56% | 39.238B 7.73% | 43.437B 10.70% | 48.313B 11.23% | 49.06B 1.55% | 53.955B 9.98% | 56.846B 5.36% | 59.927B 5.42% | 63.194B 5.45% | |
| Operating Margin | 8.33% | 8.77% | 8.71% | 8.99% | 8.63% | 8.85% | 9.10% | 8.36% | 8.93% | 8.87% | 8.83% | 8.79% | |
| EPS YoY % growth | 19.01 12.69% | 22.19 16.73% | 25.12 13.20% | 27.89 11.15% | 30.03 7.55% | 33.84 12.69% | 38.44 13.60% | 43.64 13.52% | 49.67 13.83% | 55.09 10.90% | 61.13 10.96% | 67.86 11.02% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 7.36 2.75% | 7.54 10.86% | 7.69 7.56% | 7.42 8.90% | 8.51 15.67% | 8.48 12.51% | 8.66 12.62% | 8.12 9.53% | 9.53 12.04% | 9.62 13.43% | 9.65 11.43% | 8.65 6.44% |
| Revenue Q2Q % growth | 112.336B 12.25% | 113.245B 14.30% | 114.729B 13.80% | 115.633B 14.71% | 121.53B 8.18% | 122.406B 8.09% | 123.53B 7.67% | 124.309B 7.50% | 127.395B 4.83% | 129.18B 5.53% | 130.619B 5.74% | 130.332B 4.85% |
| EBITDA Q2Q % growth | 10.703B 19.88% | 10.81B 9.28% | 11.005B -6.47% | 10.259B 3.33% | 11.82B 10.44% | 11.971B 10.74% | 12.131B 10.23% | 11.245B 9.61% | 12.961B 9.65% | 13.07B 9.18% | 13.093B 7.93% | 11.998B 6.70% |
| EBIT Q2Q % growth | 9.65B 21.67% | 9.839B 24.94% | 10.052B 15.43% | 9.561B 4.30% | 10.886B 12.81% | 11.155B 13.38% | 11.26B 12.02% | 10.341B 8.16% | 11.809B 8.48% | 11.908B 6.75% | 11.921B 5.87% | 10.819B 4.62% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 6.81 10.55% | 6.79 | 0.02 | 0.29% |
| Q3 2024 Q2Q % growth | 7.15 8.99% | 7.07 | 0.08 | 1.12% |
| Q2 2024 Q2Q % growth | 6.80 10.75% | 6.73 | 0.07 | 1.10% |
| Q1 2024 Q2Q % growth | 7.16 14.38% | 6.68 | 0.48 | 7.17% |
| Q4 2023 Q2Q % growth | 6.16 15.36% | 6.04 | 0.12 | 1.96% |
| Q3 2023 Q2Q % growth | 6.56 13.30% | 6.38 | 0.18 | 2.79% |
| Q2 2023 Q2Q % growth | 6.14 10.23% | 6.05 | 0.09 | 1.55% |
| Q1 2023 Q2Q % growth | 6.26 14.03% | 6.19 | 0.07 | 1.17% |
| Q4 2022 Q2Q % growth | 5.34 19.20% | 5.22 | 0.12 | 2.31% |
| Q3 2022 Q2Q % growth | 5.79 28.10% | 5.48 | 0.31 | 5.74% |
| Q2 2022 Q2Q % growth | 5.57 18.51% | 5.25 | 0.32 | 6.07% |
| Q1 2022 Q2Q % growth | 5.49 3.39% | 5.43 | 0.06 | 1.10% |
| Q4 2021 Q2Q % growth | 4.48 77.78% | 4.35 | 0.13 | 3.02% |
| Q3 2021 Q2Q % growth | 4.52 28.77% | 4.45 | 0.07 | 1.48% |
| Q2 2021 Q2Q % growth | 4.70 -33.99% | 4.48 | 0.22 | 4.95% |
| Q1 2021 Q2Q % growth | 5.31 42.74% | 4.43 | 0.88 | 19.95% |
| Q4 2020 Q2Q % growth | 2.52 -35.38% | 2.44 | 0.08 | 3.42% |
| Q3 2020 Q2Q % growth | 3.51 -9.54% | 3.12 | 0.39 | 12.37% |
| Q2 2020 Q2Q % growth | 7.12 97.78% | 5.33 | 1.79 | 33.60% |
| Q1 2020 Q2Q % growth | 3.72 -0.27% | 3.66 | 0.06 | 1.58% |
| Q4 2019 Q2Q % growth | 3.90 | 3.81 | 0.09 | 2.31% |
| Q3 2019 Q2Q % growth | 3.88 | 3.78 | 0.10 | 2.53% |
| Q2 2019 Q2Q % growth | 3.60 | 3.49 | 0.11 | 3.24% |
| Q1 2019 Q2Q % growth | 3.73 | 3.63 | 0.10 | 2.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 100.807B 6.76% | 102.776B | -1.969B | -1.92% |
| Q3 2024 Q2Q % growth | 100.82B 9.16% | 100.272B | 548M | 0.55% |
| Q2 2024 Q2Q % growth | 99.075B 6.64% | 99.824B | -749M | -0.75% |
| Q1 2024 Q2Q % growth | 100.075B 8.86% | 100.256B | -181M | -0.18% |
| Q4 2023 Q2Q % growth | 94.427B 14.06% | 93.085B | 1.342B | 1.44% |
| Q3 2023 Q2Q % growth | 92.361B 14.18% | 92.325B | 36M | 0.04% |
| Q2 2023 Q2Q % growth | 92.903B 15.65% | 91.917B | 986M | 1.07% |
| Q1 2023 Q2Q % growth | 91.931B 14.70% | 90.677B | 1.254B | 1.38% |
| Q4 2022 Q2Q % growth | 82.787B 12.26% | 83.416B | -629M | -0.75% |
| Q3 2022 Q2Q % growth | 80.894B 11.83% | 81.308B | -414M | -0.51% |
| Q2 2022 Q2Q % growth | 80.332B 12.63% | 80.48B | -148M | -0.18% |
| Q1 2022 Q2Q % growth | 80.149B 14.18% | 79.574B | 575M | 0.72% |
| Q4 2021 Q2Q % growth | 73.743B 12.64% | 73.476B | 267M | 0.36% |
| Q3 2021 Q2Q % growth | 72.337B 11.09% | 71.941B | 396M | 0.55% |
| Q2 2021 Q2Q % growth | 71.321B 14.78% | 70.17B | 1.151B | 1.64% |
| Q1 2021 Q2Q % growth | 70.196B 8.96% | 69.909B | 287M | 0.41% |
| Q4 2020 Q2Q % growth | 65.467B 7.50% | 65.713B | -246M | -0.37% |
| Q3 2020 Q2Q % growth | 65.115B 7.89% | 64.522B | 593M | 0.92% |
| Q2 2020 Q2Q % growth | 62.138B 2.55% | 64.131B | -1.993B | -3.11% |
| Q1 2020 Q2Q % growth | 64.421B 6.82% | 64.961B | -540M | -0.83% |
| Q4 2019 Q2Q % growth | 60.901B | 61.646B | -745M | -1.21% |
| Q3 2019 Q2Q % growth | 60.351B | 60.388B | -37M | -0.06% |
| Q2 2019 Q2Q % growth | 60.595B | 61.156B | -561M | -0.92% |
| Q1 2019 Q2Q % growth | 60.308B | 60.306B | 2M | 0.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.12% | -0.13% | -0.03% | 0% |
| Revenue | 0.09% | 0.09% | 0.01% | 0.05% |